Secondary haematological malignancies after radioimmunotherapy

Annals of Hematology

Volumn 91, Issue 6, 2012, Pages 969-

  Gigli, Federica ^a,b   Gardellini, Angelo ^a,b   Bertazzoni, Paola ^a,b   Martinelli, Giovanni ^a,b  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYTARABINE; DAUNORUBICIN; DOTATOC LU 177; DOTATOC Y 90; HEMOGLOBIN; RADIOISOTOPE; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; CANCER LOCALIZATION; CANCER RESISTANCE; CASE REPORT; DEATH; DYSPLASIA; FOLLOW UP; HUMAN; INTESTINE TUMOR; KARYOTYPE; LETTER; LEUKOCYTE COUNT; MALE; NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; PROSTATE TUMOR; RADIOIMMUNOTHERAPY; THROMBOCYTE COUNT;

EID: 84862705564     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-011-1345-6     Document Type: Letter

References (1)

1. Piccin A, Grana CM, Negri G, Pusceddu I, Paganelli G, Cortelazzo S (2011) Secondary acute myeloid leukemia after peptide receptor radionuclide therapy. Ann Hematol. doi:10. 1007/s00277-011-1237-9